Abstract
Challenges in pharmaceutical drug development: A study of ranitidine hydrochloride polymorphism. N Chieng, D Saville, T Rades.
Factors associated with finger and thumb injury in netball players. G Donaldson, SJ Sullivan, A Thurston, G Johnson.
Naturally occurring flavonoids baicalein and baicalin as putative modulators of GABAA receptors. L Huang, G Lees.
Soluble forms of the major transplantation antigens MHC class I and II are not associated with exosome structures in human or murine blood. P MacKay, RW Jack, N Koch, S LeibundGut-Landmann, W Reith, AD McLellan.
Epigallocatechin-gallate and tamoxifen: a novel drug treatment in a murine model of estrogen receptor negative breast cancer. AR Menzies, MJ Scandlyn, MJ Le Nedelec, EC Stuart, RJ Rosengren.
Transgelin: discovering its role in prostate cancer progression. P Prasad, J Stanton, S Assinder.
Cost-efficacy of TPMT testing prior to azathioprine therapy. V Priest, EJ Begg, SJ Gardiner, CMA Frampton, RB Gearry, ML Barclay, DWJ Clark.
The constitutive expression of HPV16 E6 in HCT116 cells leads to a reduction in E-cadherin levels that can not be counteracted by indole-3-carbinol or tamoxifen. J Shields, M Hibma.
Epigallocatechin gallate and curcumin synergistically induce G2/M-phase arrest in MDA-MB-231 human breast cancer cells. TJ Somers-Edgar, EC Stuart, RJ Rosengren.
Neurotrophin-3 loss in vivo does not affect myelination at birth, but reduces myelination at three weeks in mice. KJ Tait, AG Woolley, MJ Duxson.